142 related articles for article (PubMed ID: 9570569)
1. Subcongenic analysis of the Idd13 locus in NOD/Lt mice: evidence for several susceptibility genes including a possible diabetogenic role for beta 2-microglobulin.
Serreze DV; Bridgett M; Chapman HD; Chen E; Richard SD; Leiter EH
J Immunol; 1998 Feb; 160(3):1472-8. PubMed ID: 9570569
[TBL] [Abstract][Full Text] [Related]
2. Conditioning the genome identifies additional diabetes resistance loci in Type I diabetes resistant NOR/Lt mice.
Reifsnyder PC; Li R; Silveira PA; Churchill G; Serreze DV; Leiter EH
Genes Immun; 2005 Sep; 6(6):528-38. PubMed ID: 16015371
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of H2-Db class I molecules containing two different allelic forms of the type 1 diabetes susceptibility factor beta-2 microglobulin: implications for the mechanism underlying variations in antigen presentation.
Roden MM; Brims DR; Fedorov AA; DiLorenzo TP; Almo SC; Nathenson SG
Mol Immunol; 2006 Mar; 43(9):1370-8. PubMed ID: 16229893
[TBL] [Abstract][Full Text] [Related]
4. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice.
Serreze DV; Gaskins HR; Leiter EH
J Immunol; 1993 Mar; 150(6):2534-43. PubMed ID: 8450229
[TBL] [Abstract][Full Text] [Related]
5. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium.
Serreze DV; Leiter EH
J Immunol; 1991 Aug; 147(4):1222-9. PubMed ID: 1869820
[TBL] [Abstract][Full Text] [Related]
6. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy.
Brayer J; Lowry J; Cha S; Robinson CP; Yamachika S; Peck AB; Humphreys-Beher MG
J Rheumatol; 2000 Aug; 27(8):1896-904. PubMed ID: 10955330
[TBL] [Abstract][Full Text] [Related]
7. Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity.
Verdaguer J; Amrani A; Anderson B; Schmidt D; Santamaria P
J Immunol; 1999 Apr; 162(8):4614-26. PubMed ID: 10202001
[TBL] [Abstract][Full Text] [Related]
8. Crosses of NOD mice with the related NON strain. A polygenic model for IDDM.
McAleer MA; Reifsnyder P; Palmer SM; Prochazka M; Love JM; Copeman JB; Powell EE; Rodrigues NR; Prins JB; Serreze DV
Diabetes; 1995 Oct; 44(10):1186-95. PubMed ID: 7556956
[TBL] [Abstract][Full Text] [Related]
9. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
Yoshida K; Kikutani H
Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
[TBL] [Abstract][Full Text] [Related]
10. Cellular expression requirements for inhibition of type 1 diabetes by a dominantly protective major histocompatibility complex haplotype.
Chen YG; Silveira PA; Osborne MA; Chapman HD; Serreze DV
Diabetes; 2007 Feb; 56(2):424-30. PubMed ID: 17259387
[TBL] [Abstract][Full Text] [Related]
11. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
12. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
13. MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice.
Serreze DV; Gallichan WS; Snider DP; Croitoru K; Rosenthal KL; Leiter EH; Christianson GJ; Dudley ME; Roopenian DC
Diabetes; 1996 Jul; 45(7):902-8. PubMed ID: 8666141
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
Mora C; Wong FS; Chang CH; Flavell RA
J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997
[TBL] [Abstract][Full Text] [Related]
15. Transgenic rescue implicates beta2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice.
Hamilton-Williams EE; Serreze DV; Charlton B; Johnson EA; Marron MP; Mullbacher A; Slattery RM
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11533-8. PubMed ID: 11572996
[TBL] [Abstract][Full Text] [Related]
16. MHC-linked susceptibility to type 1 diabetes in the NOD mouse: further localization of Idd16 by subcongenic analysis.
Fujisawa T; Ikegami H; Noso S; Yamaji K; Nojima K; Babaya N; Itoi-Babaya M; Hiromine Y; Kobayashi M; Makino S; Ogihara T
Ann N Y Acad Sci; 2006 Oct; 1079():118-21. PubMed ID: 17130541
[TBL] [Abstract][Full Text] [Related]
17. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
[TBL] [Abstract][Full Text] [Related]
18. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors.
Silveira PA; Johnson E; Chapman HD; Bui T; Tisch RM; Serreze DV
Eur J Immunol; 2002 Dec; 32(12):3657-66. PubMed ID: 12516557
[TBL] [Abstract][Full Text] [Related]
19. The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice.
DiLorenzo TP; Serreze DV
Immunol Rev; 2005 Apr; 204():250-63. PubMed ID: 15790363
[TBL] [Abstract][Full Text] [Related]
20. MHC-linked diabetogenic gene of the NOD mouse: molecular mapping of the 3' boundary of the diabetogenic region.
Ikegami H; Kawaguchi Y; Ueda H; Fukuda M; Takakawa K; Fujioka Y; Fujisawa T; Uchida K; Ogihara T
Biochem Biophys Res Commun; 1993 Apr; 192(2):677-82. PubMed ID: 8097912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
